Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells.
Shin SH, Lee JS, Zhang JM, Choi S, Boskovic ZV, Zhao R, Song M, Wang R, Tian J, Lee MH, Kim JH, Jeong M, Lee JH, Petukhov M, Lee SW, Kim SG, Zou L, Byun S.
Shin SH, et al. Among authors: byun s.
Sci Adv. 2020 Jul 31;6(31):eaay9131. doi: 10.1126/sciadv.aay9131. eCollection 2020 Jul.
Sci Adv. 2020.
PMID: 32789167
Free PMC article.